文献速递皮肤肿瘤

离体皮肤镜联合真皮点标记在皮肤肿瘤病理评估中的应用

Pathologic Evaluation of Skin Tumors With Ex Vivo Dermoscopy With Derm Dotting.
PubMed 文献 · JAMA Dermatol · 2017-01-01

结果显示EVD+DD提高了非黑素细胞皮肤癌切缘阳性检出率、痣的特定诊断率及黑色素瘤溃疡和碰撞病变的检出,并缩短了周转时间。结论支持皮肤病理医生学习皮肤镜并采用病灶导向的DD引导切片。

要点

  • EVD+DD使非黑素细胞皮肤癌切缘阳性检出率从8.4%升至12.8%。
  • EVD+DD使痣的特定临床病理诊断率从10.3%升至27.7%。
  • EVD+DD缩短了痣、黑色素瘤和基底细胞癌的周转时间。

核心结论

  • 在皮肤病理环境中,EVD联合DD及适配切片可实现更准确且省时的皮肤肿瘤组织病理诊断。
  • 建议皮肤肿瘤评估相关病理医生学习皮肤镜,并以病灶特异性DD引导切片替代随机横切。

研究设计与样本

  • 两期标本由同一皮肤病理医生诊断,前组来自医院普通病理实验室,后组来自私立皮肤病理实验室。

主要发现

  • 非黑素细胞皮肤癌切缘阳性检出率从8.4%升至12.8%,以Bowen病、侵袭性鳞状细胞癌和浅表型基底细胞癌增幅最显著。
  • 痣的特定临床病理诊断率从10.3%升至27.7%,中度和重度异型痣发生率分别从1.0%升至7.2%和从0.6%升至1.4%。
  • 厚度>1 mm黑色素瘤溃疡检出率从24.0%升至31.3%,痣相关黑色素瘤从15.5%升至33.3%,碰撞病变从0.07%升至1.07%。
  • 痣的周转时间从2天降至1天,黑色素瘤从5天降至2天,基底细胞癌从2天降至1天。

关键数值与推荐

  • EVD+DD使非黑素细胞皮肤癌切缘阳性检出率从8.4%升至12.8%。
  • EVD+DD使痣的特定诊断率从10.3%升至27.7%,中度异型痣从1.0%升至7.2%,重度从0.6%升至1.4%。
  • 厚度>1 mm黑色素瘤溃疡检出率从24.0%升至31.3%,痣相关黑色素瘤从15.5%升至33.3%,碰撞病变从0.07%升至1.07%。
  • 周转时间:痣从2天降至1天,黑色素瘤从5天降至2天,基底细胞癌从2天降至1天。

临床怎么用

  • 皮肤病理医生可学习皮肤镜,采用EVD+DD引导的病灶特异性切片替代随机横切。
  • 该技术有助于提高切缘阳性、异型痣、黑色素瘤溃疡和碰撞病变的检出。
  • EVD+DD可缩短痣、黑色素瘤和基底细胞癌的病理周转时间。

局限性

  • 回顾性研究,两期标本来自不同实验室(医院普通病理与私立皮肤病理),可能存在机构差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Ex vivo dermoscopy (EVD) with derm dotting (DD) improves clinicopathologic correlation and the quality of diagnosis in skin tumors. OBJECTIVE: To compare the diagnostic performance of the standard method of skin biopsy processing with the practice of EVD with DD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study compares the diagnostic performance in 6526 skin biopsy specimens examined from 2008 to 2010 with a standard method of processing with 8584 biopsy specimens examined in 2015 with EVD and DD. Data were analyzed from January 1 to March 31, 2016. A total of 15 110 skin biopsy specimens were included. The biopsy specimens from 2008 to 2010 were processed in a hospital-based general pathology laboratory; the biopsy specimens from 2015 were processed in a private dermatopathology laboratory. Biopsy specimens from both periods were diagnosed by the same dermatopathologist. MAIN OUTCOMES AND MEASURES: The primary outcome measures were clinicopathological characteristics, usefulness of EVD with DD, and turnaround times (TATs). RESULTS: Use of EVD with DD increased the detection of positive section margins in nonmelanoma skin cancer from 8.4% to 12.8%. The most significant increase was seen in Bowen disease, invasive squamous cell carcinoma, and a superficial type of basal cell carcinoma (BCC). With EVD and DD, a specific clinicopathologic diagnosis was made in 27.7% of nevi compared with only 10.3% using the standard method. The incidence of moderately and severely dysplastic nevi increased from 1.0% to 7.2% and from 0.6% to 1.4%, respectively. The detection of ulceration in melanomas with thicker than 1 mm increased from 24.0% to 31.3%. The number of nevi-associated melanomas increased from 15.5% to 33.3%. The number of collision lesions from 0.07% to 1.07%. The TAT for nevi decreased from 2 days to 1 day, for melanomas from 5 days to 2 days, and for BCC from 2 days to 1 day. CONCLUSIONS AND RELEVANCE: Ex vivo dermoscopy and DD with adapted sectioning in a dermatopathology setting allows a more accurate and less time consuming histopathologic diagnosis of skin tumors. These findings suggest that pathologists involved in skin tumor evaluation should be encouraged to learn dermoscopy and replace random transverse cutting with lesion-specific and DD-guided cutting.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Haspeslagh M, Hoorens I, Degryse N, et al. Pathologic Evaluation of Skin Tumors With Ex Vivo Dermoscopy With Derm Dotting. JAMA Dermatol. 2017. PMID: 28030717. doi:10.1001/jamadermatol.2016.4444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。